BiotechTube
Home/Organogenesis/David C. Francisco
DC

David C. Francisco

Chief Financial Officer

Organogenesis

Therapeutic Areas

Advanced Wound CareSurgical BiologicsSports Medicine

Organogenesis Pipeline

DrugIndicationPhase
ApligrafDiabetic Foot Ulcers, Venous Leg UlcersApproved/Commercial
DermagraftDiabetic Foot UlcersApproved/Commercial
PuraPry / PuraPly AMVarious acute and chronic woundsApproved/Commercial
NuCelSurgical and orthopedic applicationsApproved/Commercial
AffinitySurgical and orthopedic applicationsApproved/Commercial
ReNuSurgical and orthopedic applicationsApproved/Commercial

Leadership Team at Organogenesis

GS
Gary S. Gillheeney, Sr.
President, Chief Executive Officer and Chair of the Board
PB
Patrick Bilbo
Chief Operating Officer
BG
Brian Grow
Chief Commercial Officer
View full Organogenesis profile